The webinar to find what’s MISSING in your UI protocol
There’s a gap in managing urinary incontinence (UI), and it’s not medical. UI frays the bond between dogs and their families—often before you’re aware they’re struggling.
A more complete protocol helps identify at-risk patients early, drives long-term treatment success, and boosts practice efficiency. Most important, it helps keep dogs with their families where they belong.
Host: Ernie Ward, DVM, CVFT
Host: Ernie Ward, DVM, CVFT
Complete the form below for instant access to the webinar
Webinar sneak peek from Dr. Ward
Get the elements for a more complete UI protocol
Patient Identification
Ongoing Management
Client Education
Compliance
Register to access the webinar
Complete this form for instant access to the webinar. We’ll also send a link to your email so you can watch it on demand at your convenience. PRN Pharmacal or its representatives may use the information provided to follow up regarding this webinar, Proin ER, and related educational resources.
"*" indicates required fields
PROIN ER is the only FDA-approved once-daily medication for the control of canine urinary incontinence (UI) due to urethral sphincter hypotonus.
Indication
PROIN ER is indicated for the control of urinary incontinence due to urethral sphincter hypotonus in dogs.
Benefits
A First-Line UI Treatment Per ACVIM Consensus1
PROIN ER is indicated for the control of canine UI due to urethral sphincter hypotonus.
Treatment Compliance
Simple once-daily dosing helps clients adhere to treatment, which can improve patient outcomes.1
Cost-Effective
Lower cost of treatment can make quality care more accessible and offer long-term affordability for pet owners.
Consistent Control
Patented extended-release technology provides controlled delivery that ensures steady absorption, reducing the occurrence of UI episodes.
Broad Tolerability
Formulated with hydrolyzed protein, making it an alternative for dogs with dietary sensitivities.*
1Kendall A, Byron JK, Westropp JL, Coates JR, Vaden S, Adin C, Oetelaar G, Bartges JW, Foster JD, Adams LG, Olby N, Berent A. ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs. J Vet Intern Med. 2024 Mar-Apr;38(2):878-903. doi: 10.1111/jvim.16975. Epub 2024 Jan 13. PMID: 38217372; PMCID: PMC10937496.
2Barter LS et al. 2015; Adams VJ et al. J Small Anim Pract. 2005.
*While hydrolyzed proteins reduce the risk of immunologic reactivity, individual sensitivities may still occur.